Sunteți pe pagina 1din 2

DAFTAR RUJUKAN

1. Tavasolli, Devilee R. Pathology and Genetic of Tumours of the Breast and


Female Genital Organs/ WHO Classification of Tumours. IARC Press.
2003: 34-6.
2. Berek. Jonathan S. Breast Cancer in Novaks Gynecology. thirteen edition.
Lippincott Williams & Wilkins.2002: 1375-93.
3. Kanker
Payudara.[cited:
2009/12/10/].
available
from:
http://www.fortunestar.co.id
4. Breast
Cancer-Male.
[cited:
2009/12/10].available
from:
http://www.cancer.net-Breast Cancer-Male
5. Patten Bradley M. Human Embriology.second edition. Mc.Graw-Hill.240-1
6. Kissane. John M. Andersons Pathology. volume II. 9th edition.
Mosby.1990: 1726-48
7. Juan Rosai. Ackermans Surgical Pathology. volume I. 9th edition. Mosby.
2004: 52-3. 2098-9.
8. Sjamsuhidajat R. de Jong. Buku Ajar Ilmu Bedah. EGC. 2000: 534-5
9. Tan, P.H.2001. Pathology of Ductal Carcinoma in Situ of The Breast: A
Heterogeneous of Greater Understanding. Ann Acad Med Singapore. 30:
672-6.
10. Cotton, RE. Lecture Notes on Pathology. fourth edition. Blackwell
Scientific publications. 1992: 53-5.
11. Mills Stacey et all. Stenbergs Diagnostic Surgical Pathology. volume IIB.
4th edition. Lippincott Williams & Wilkins. 2004: 332-3
12. Kumar. Abbas. Robbins and Cotran Pathologic Basis of Disease. 7th edition.
Elsevier. 2005: 96. 296. 1119-51.
13. Robbins et all. Basic Pathology. 7th edition. Saunders. 2003: 705-17.
14. Anderdon. Famale Reproductive System. Volume 6. Churchill Livingstone.
1991: 208. 212. 215-218
15. Breast Cancer Genes and Inheritance. [cited : 2009/12/10] available from:
http://familycancer.org/FamHist.5tm
16. Tapia C., Savic S., Wagner. 2007. Her2 Gene Status in Primary Breast
Cancer and Matched Distant Metastasis. Breast Cancer Research.
17. Scheuner Maren T. Hereditary Breast Cancer. in Management of Breast
Disease. Cedar-Sinai Medical Center.2007
18. Crum. C.P. Diagnostic Gynecologic and and Obstetric Pathology. Elsevier.
2006: 802-3.
19. Nadji mehrdad, Fernandez C., Gomez., Parvin. Immunohistochemistry of
Estroge and Progesterone Receptors Reconsidered. AmJClinPathol.2005:
129: 21-27

52
Universitas Sumatera Utara

20. Moriki,T.,Tamotsu Takashi. Hormone Reseptor Status and HER2/neu


overexpression determined by automated imunostainer on routinely fixed
cytologic specimens from breast carcinoma : Correlation with histologic
sections determinations and Diagnostic Pitfalls, Abstract, Diagnostic
Cytopathology.2006: 30(4): 251-6
21. Research Advocacy Network and NCCN. HER2 Testing: Summary for
Breast Cancer Patients, Based on the NCCN Task Force Report:HER2
Testing in Breast Cancer.2006.
22. Chandrasoma et all, 2001. Concise Pathology. 3rd edition. McGraw-Hill
International Edition. 742-55
23. Rubin,et all. Pathology.third edition. volume II. Lippincott Williams &
Wilkins.2003: 1039-46
24. Rosen, P.Peter. Breast Pathology. Volume I. Second edition. Lippincott.
Philadelphia.2001: 236-56
25. King, Bonnie L, Susan M, Love, et all. The fourth International Symposium
on the Intraductal Approach to Breast Cancer. Santa Barbara. California.
Breast Cancer Research. 2005.7.198-204
26. Breast Cancer.[cited: 2009/12/10]. Available from: http://www.meded.virginia.edu/Courses/path/gyn/breast
27. Nozoe T, Mori E, Ninomiya M, Maeda T, Matsukuma A, Nakashima H,
Ezaki T. Squamous Cell Carcinoma of the Breast. The Japanese Breast
Cancer Society 2009; DOI : 10.1007/s12282-009-1=0146-4.
28. Protocol Applied to All Invasion carcinoma of the Breast.[cited:
2009/12/10]
Available
from
:
www.cap.org/apps/docs/commitees/cancer/cancer protocols/2005/breast05
ckw.pdf
29. Okada K,Makihara K. A Case of Primary Squamous Cell carcinoma of the
Breast with Rapid progression. Breast Cancer 2000:Vol.7 No.2
30. Sudigdo S.,Sofyan I.Dasar-Dasar Metodologi Penelitian Klinis.
Jakarta.ISBN.2008

LAMPIRAN
Lampiran 1

Universitas Sumatera Utara

S-ar putea să vă placă și